Pemetrexed Injection Market size is estimated to be USD 1.5 Billion in 2024 and is expected to reach USD 2.8 Billion by 2033 at a CAGR of 7.5% from 2026 to 2033.
The Pemetrexed Injection Market in South Korea is experiencing significant growth, driven by the increasing prevalence of non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma. This surge is further supported by the country's robust healthcare infrastructure and a growing emphasis on advanced oncology treatments.
In South Korea, the market is segmented into branded and generic pemetrexed injections. Branded versions, such as Eli Lilly's Alimta, have established a strong presence due to their proven efficacy and trust among healthcare professionals. However, the expiration of patents has paved the way for generic variants, offering cost-effective alternatives without compromising on quality. This shift is crucial for healthcare providers aiming to manage treatment costs while maintaining high standards of patient care.
The demand for pemetrexed injections is predominantly met through hospital pharmacies, which account for a significant share of the distribution channel. The preference for hospital-based administration stems from the need for professional supervision during chemotherapy sessions. Nonetheless, there's a noticeable trend towards the adoption of self-injectable devices, enhancing patient convenience and adherence to treatment protocols.
South Korea's pharmaceutical industry is actively engaging in research and development to innovate drug delivery mechanisms. Collaborations between local biotech firms and international pharmaceutical companies are fostering the development of advanced injectable formulations, aiming to improve therapeutic outcomes and patient experiences.
Furthermore, the government's supportive policies and investment in healthcare infrastructure are facilitating the rapid integration of these treatments into the national healthcare system. As a result, South Korea is poised to become a key player in the global pemetrexed injection market, balancing innovation with accessibility to meet the evolving needs of cancer patients.
Get an In-Depth Research Analysis of the South Korea Pemetrexed Injection Market Size And Forecast [2025-2032]
Eagle Pharmaceuticals
AuroMedics Pharma
Teva Pharmaceutical Industries
Taro Pharma
Seacross Pharmaceuticals
Simcere Pharmaceutical Group
Qilu Pharmaceutical
Pfizer
Jiangsu Anda Pharmaceutical
Yangtze River Pharmaceutical Group
Hansoh Pharmaceutical Group Company
Nanjing Pharmaceutical Factory
DEYAO PHARMA
Vianex S.A.-Plant C
Hainan Jinrui Pharmaceutical
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the South Korea Pemetrexed Injection Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the South Korea Pemetrexed Injection Market
Single Dose Vials
Multi-Dose Vials
Pre-filled Syringes
Intravenous Infusion Bags
Non-Small Cell Lung Cancer (NSCLC)
Mesothelioma
Other Solid Tumors
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Specialty Pharmacies
Hospitals
Oncology Clinics
Ambulatory Surgical Centers
Home Healthcare Settings
Intravenous Administration
Intramuscular Administration
Subcutaneous Administration
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ South Korea Pemetrexed Injection Market Research Analysis
1. Introduction of the South Korea Pemetrexed Injection Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. South Korea Pemetrexed Injection Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. South Korea Pemetrexed Injection Market, By Type
6. South Korea Pemetrexed Injection Market, By Application
7. South Korea Pemetrexed Injection Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. South Korea Pemetrexed Injection Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/